Book of abstracts version 5
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Synthesis <strong>of</strong> a terpyridine ligand for the application in photodynamic therapy<br />
Author<br />
terpyrdine Timo van Veen ligand for the application in photodynamic therapy<br />
Academy <strong>of</strong> Technology for Health and Environment<br />
Avans Hogeschool, Breda<br />
University <strong>of</strong> Leiden<br />
Abstract<br />
Worldwide is cancer one <strong>of</strong> the biggest causes <strong>of</strong> death [1]. A relatively new cure for cancer is called “Photo dynamic<br />
therapy”. In comparison with chemotherapy, photo dynamic therapy is an easier medication method for the patient. For<br />
this therapy a photo dynamic medicine is needed. The goal <strong>of</strong> this research is to synthesize this photo dynamic medicine,<br />
the ligand [2,2’:6,2”- terpyridine]-4’-ylmethanol. This ligand is shown in Figure 1. This ligand is able to form a complex with<br />
ruthenium. When a laser is applied on this complex it will become toxic for the tumour [2] . To synthesize this ligand a 4<br />
step synthesis is carried out. This reaction equation is shown in Figure 2. The first step is a reaction known as the furan<br />
pathway, with acetyl pyridine and furfural under basic conditions to form 4’-(Furan-2-yl)-2,2’:6’,2”-terpyridine. Step 2 is an<br />
oxidation with KMnO4 to synthesize [2,2':6',2''-terpyridine]-carboxylic acid. Next there will be a Fischer esterification to<br />
synthesize (Methyl)-2,2':6',2''-Terpyridine-4'-carboxylate. The final step is to reduce the ester product towards the goal<br />
molecule [2,2’:6,2”- terpyridine]-4’-ylmethanol by using NaBH4 [3] . All obtained products are purified by recrystallization<br />
and analysed by FTIR and 1 H-NMR.<br />
Keywords: Photo dynamic therapy, Terpyridine derivative, The furan pathway<br />
Table <strong>of</strong> content<br />
Figure 1: The goal molecule.<br />
Figure 2: Overall reaction equation<br />
[1] L. Torre, F. Bray, R. Siegel, J. Ferlay, J. Lortet-Tieulent en A. Jemal, „Global cancer statistics 2012,” Cancer Journal, nr.<br />
65, pp. 87-108, 2015.<br />
[2] V. Brabec en O. Nováková, „DNA binding mode <strong>of</strong> ruthenium complexes and relationship to tumor cell toxicity,” Drug<br />
Resistance Updates, nr. 9, pp. 111-122, 2006.<br />
[3] M. Heller en U. S. Schubert, „Functionalized 2,2′-Bipyridines and 2,2′:6′,2′′-Terpyridines via Stille-Type Cross-Coupling<br />
Procedures,” Journal <strong>of</strong> inorganic chemistry, pp. 8269 -8272, 2002.<br />
67